Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer
在患有高级别非肌层浸润性膀胱癌的患者中,人工智能驱动的预测性生物标志物的存在与膀胱内卡介苗治疗反应不良相关,但与膀胱内序贯吉西他滨/多西他赛治疗反应不良无关。
期刊:European Urology Oncology
影响因子:9.3
doi:10.1016/j.euo.2025.04.006
Packiam, Vignesh T; McElree, Ian M; Ghodoussipour, Saum; Nimgaonkar, Vivek; Krishna, Viswesh; Kim, Joon Kyung; Allison, Derek B; Richards, Jordan R; Anand Rajan, K D; Chen, Stephanie J; Lotan, Yair; Williams, Stephen B; Zhang, Haochen; Watson, Drew; Vrabac, Damir; Abuzeid, Waleed M; Joshi, Anirudh; Kamat, Ashish M; O'Donnell, Michael A; Hensley, Patrick J